A comparison of frequencies of FoxP3+ cells within the CD4+ T cell subset for tumor associated cells and blood (PBMC) for each patient revealed a significantly higher frequency of FoxP3+ cells in tumor vs. blood for each patient (Figures 7C,D) (p = 0.001). This evidence concerns the gene FOXP3 and neoplasm.